"' Argininemia "', also called "'arginase deficiency "', is an autosomal recessive urea cycle disorder where a deficiency of the enzyme arginase causes a buildup of arginine and ammonia in the blood.
42.
"' Argininemia "', also called "'arginase deficiency "', is an autosomal recessive urea cycle disorder where a deficiency of the enzyme arginase causes a buildup of arginine and ammonia in the blood.
43.
Additionally, 2 ( S )-amino-6-boronohexonic acid ( ABH ) is an L-arginine analogue that also creates a tetrahedral intermediate similar to that formed in the catalysis of the natural substrate, and is a potent inhibitor of human arginase I.
44.
However, since NO synthase and arginase compete for the same substrate ( L-arginine ), over-expressed arginase can affect NO synthase activity and NO-dependent smooth muscle relaxation by depleting the substrate pool of L-arginine that would otherwise be available to NO synthase.
45.
However, since NO synthase and arginase compete for the same substrate ( L-arginine ), over-expressed arginase can affect NO synthase activity and NO-dependent smooth muscle relaxation by depleting the substrate pool of L-arginine that would otherwise be available to NO synthase.
46.
The active site of MetAP2 has a structural motif characteristic of many metalloenzymes including the dioxygen carrier protein, hemerythrin; the dinuclear non-heme iron protein, ribonucleotide reductase; leucine aminopeptidase; urease; arginase; several phosphatases and phosphoesterases that includes two bridging carboxylate ligands and a bridging water or hydroxide ligand.
